Even mild visual field loss can have serious on-road consequences. Here’s guidance.
One surgeon shares strategies he's used to ensure more timely movement through the office—and happier patients.
Observing and measuring change becomes challenging when the disease is advanced. Here's help.
Advances in genetic manipulation are showing promise for mitigating glaucomatous damage and preserving sight.
Some prescription and OTC treatments our patients may be receiving can affect the disease—for better or worse.
Doing surgery on these patients requires a different approach than you might use for other glaucoma patients. Here's help.
Evidence suggests that these drugs cause a long-term IOP reduction in some patients. Here's the latest.
Patients are increasingly curious about this. A doctor/researcher provides an update.
A number of these procedures, including anti-VEGF injections, can trigger a rise in IOP. A retinal specialist offers advice.
Pharmacy-made drops can be an affordable and beneficial option for many of our patients.